{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:07:31Z","timestamp":1793639251138,"version":"4.5.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>We aimed to identify B-cell-mediated immunomechanisms in inclusion body myositis (IBM) and polymyositis (PM) as part of the complex pathophysiology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Human primary myotube cultures were derived from orthopedic surgery. Diagnostic biopsy specimens from patients with IBM (n=9) and PM (n=9) were analyzed for markers of B cell activation (BAFF and APRIL) and for chemokines that control the recruitment of B cells (CXCL-12 and CXCL-13). Results were compared to biopsy specimens without myopathic changes (n=9) and hereditary muscular dystrophy (n=9).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mRNA expression of BAFF, APRIL, and CXCL-13 was significantly higher in IBM and PM compared to controls. Patients with IBM displayed the highest number of double positive muscle fibers for BAFF and CXCL-12 (48%) compared to PM (25%), muscular dystrophy (3%), and non-myopathic controls (0%). <jats:italic>In vitro<\/jats:italic>, exposure of human myotubes to pro-inflammatory cytokines led to a significant upregulation of BAFF and CXCL-12, but APRIL and CXCL-13 remained unchanged.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results substantiate the hypothesis of an involvement of B cell-associated mechanisms in the pathophysiology of IBM and PM. Muscle fibers themselves seem to contribute to the recruitment of B cells and sustain inflammation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1177721","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T09:28:00Z","timestamp":1693906080000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Skeletal muscle fibers produce B-cell stimulatory factors in chronic myositis"],"prefix":"10.3389","volume":"14","author":[{"given":"Per-Ole","family":"Carstens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa M.","family":"M\u00fcllar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Wrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Zechel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin M.","family":"Wachowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almuth","family":"Brandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01372","article-title":"CD19+CD24hiCD38hi B cells are expanded in juvenile dermatomyositis and exhibit a pro-inflammatory phenotype after activation through toll-like receptor 7 and interferon-\u03b1","volume":"9","author":"Piper","year":"2018","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13075-020-02412-8","article-title":"Jo-1 autoantigen-specific B cells are skewed towards distinct functional b cell subsets in anti-synthetase syndrome patients","volume":"23","author":"Young-Glazer","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180308","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21739","article-title":"Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles","volume":"42","author":"Salajegheh","year":"2010","journal-title":"Muscle Nerve"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343315","article-title":"The VH repertoire and clonal diversification of B cells in inflammatory myopathies","volume":"44","author":"McIntyre","year":"2014","journal-title":"Eur J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e46709","DOI":"10.1371\/journal.pone.0046709","article-title":"Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis","volume":"7","author":"Ray","year":"2012","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis","volume":"73","author":"Benjamin Larman","year":"2013","journal-title":"Ann Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann Neurol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2005.05.003","article-title":"Immunobiology of muscle: advances in understanding an immunological microenvironment","volume":"26","author":"Wiendl","year":"2005","journal-title":"Trends Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12645","article-title":"B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL","volume":"164","author":"Ferrer","year":"2014","journal-title":"Br J Haematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.4.1676","article-title":"Cytokine control of memory b cell homing machinery","volume":"169","author":"Roy","year":"2002","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn053","article-title":"Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/art.37692","article-title":"Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and \u03b2-amyloid in the muscle","volume":"64","author":"Zsch\u00fcntzsch","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq151","article-title":"Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand","volume":"49","author":"Szodoray","year":"2010","journal-title":"Rheumatol (Oxf)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3899\/jrheum.120555","article-title":"BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies","volume":"40","author":"Lopez De Padilla","year":"2013","journal-title":"J Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2217\/bmm.13.124","article-title":"B-cell activating factor as a serological biomarker for polymyositis and dermatomyositis","volume":"8","author":"Peng","year":"2014","journal-title":"biomark Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4046-x","article-title":"Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adults","volume":"37","author":"Gupta","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.05.010","article-title":"Serum BAFF expression in patients with myasthenia gravis","volume":"199","author":"Kim","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.091405","article-title":"Increased serum levels of b cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies","volume":"68","author":"Krystufkova","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","article-title":"The expression of BAFF in the muscles of patients with dermatomyositis","volume":"249","author":"Baek","year":"2012","journal-title":"J Neuroimmunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283317b31","article-title":"Role of cytokines and chemokines in idiopathic inflammatory myopathies","volume":"21","author":"De Paepe","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1042580","article-title":"Comparison of cytokine\/chemokine profiles between dermatomyositis and anti-synthetase syndrome","volume":"13","author":"Wang","year":"2022","journal-title":"Front Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0454-8","article-title":"Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52\/anti-Ro60 autoantibodies","volume":"16","author":"Kry\u0161t\u016ffkov\u00e1","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2012.11.064","article-title":"The nonnecrotic invaded muscle fibers of polymyositis and sporadic inclusion body myositis: on the interplay of chemokines and stress proteins","volume":"535","author":"De Paepe","year":"2013","journal-title":"Neurosci Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2004.01.001","article-title":"Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies","volume":"14","author":"De Paepe","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c120033","article-title":"Muscle as a secretory organ","volume":"3","author":"Pedersen","year":"2013","journal-title":"Compr Physiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/ar1912","article-title":"B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary sj\u00f6gren\u2019s syndrome","volume":"8","author":"Ittah","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0412210","article-title":"Induction of BAFF expression by IFN-gamma via JAK\/STAT signaling pathways in human intestinal epithelial cells","volume":"93","author":"Woo","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.11.064","article-title":"c\/EBPbeta is a major regulatory element driving transcriptional activation of the CXCL12 promoter","volume":"396","author":"Calonge","year":"2010","journal-title":"J Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/boc.201200022","article-title":"Sdf-1 (CXCL12) improves skeletal muscle regeneration via the mobilisation of Cxcr4 and CD34 expressing cells","volume":"104","author":"Brzoska","year":"2012","journal-title":"Biol Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313496302","article-title":"Association of serum b cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus","volume":"22","author":"Vincent","year":"2013","journal-title":"Lupus"},{"key":"B35","doi-asserted-by":"publisher","first-page":"102736","DOI":"10.1016\/j.autrev.2020.102736","article-title":"B cell activating factor (BAFF): structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (SLE)","volume":"20","author":"M\u00f6ckel","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-93","article-title":"CXCL13 is the major determinant for b cell recruitment to the CSF during neuroinflammation","volume":"9","author":"Kowarik","year":"2012","journal-title":"J Neuroinflamm"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.06.006","article-title":"BAFF is up-regulated in central nervous system of neuro-behcet\u2019s disease","volume":"200","author":"Hamzaoui","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.07.014","article-title":"The role of BAFF in the progression of rheumatoid arthritis","volume":"76","author":"Wei","year":"2015","journal-title":"Cytokine"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140630","article-title":"Surface APRIL is elevated on myeloid cells and is associated with disease activity in patients with rheumatoid arthritis","volume":"42","author":"Weldon","year":"2015","journal-title":"J Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-00582-4","article-title":"BAFF, involved in b cell activation through the NF-\u03baB pathway, is related to disease activity and bone destruction in rheumatoid arthritis","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e000037","DOI":"10.1136\/rmdopen-2014-000037","article-title":"Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study","volume":"1","author":"Schiff","year":"2015","journal-title":"RMD Open"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2016.05.019","article-title":"Evidence for the involvement of the CXCL12 system in the adaptation of skeletal muscles to physical exercise","volume":"28","author":"Puchert","year":"2016","journal-title":"Cell Signal"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1177721\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T09:28:03Z","timestamp":1693906083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1177721\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2023.1177721"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1177721","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"article-number":"1177721"}}